Your skin is a window into biological aging. Unlike internal organs, it ages where you can see it — and where you can intervene. But understanding how to intervene requires understanding why skin ages in the first place. Not at the surface level of wrinkles and sagging. At the level of cells, mitochondria, and molecular signals.
This article is a tour of the biology. Every claim is anchored to published research. Every mechanism is named. And where the evidence is thin, I'll say so directly.
The Hallmarks Framework
In 2013, a landmark paper in the journal Cell by López-Otín and colleagues defined "The Hallmarks of Aging" — nine molecular and cellular processes that drive organismal aging. The framework was updated in 2023 to twelve hallmarks. Several of them manifest visibly in human skin: cellular senescence, mitochondrial dysfunction, loss of proteostasis, altered intercellular communication, and stem cell exhaustion.
Skin aging is not one process. It's a network of interconnected failures. Understanding them individually — and how they feed each other — is what separates evidence-based intervention from expensive hope.
Cellular Senescence: Zombie Cells
Cells don't live forever. When a cell reaches its replicative limit or suffers irreparable damage, it should die through apoptosis — a programmed, orderly shutdown. But some cells don't die. They enter a state called cellular senescence: metabolically active, permanently arrested, and secreting a toxic cocktail of inflammatory signals, proteases, and growth factors. Researchers at the Buck Institute for Research on Aging, led by Judith Campisi, have called this the senescence-associated secretory phenotype (SASP).
In young tissue, senescent cells are rare and transient — the immune system clears them. With age, clearance slows and senescent cells accumulate. In human skin, senescent fibroblasts and keratinocytes have been documented in photoaged and chronologically aged skin alike. A 2014 review by Muñoz-Espín and Serrano in Nature Reviews Molecular Cell Biology described senescence as a double-edged sword: tumour-suppressive in youth, tissue-destructive in age.
The SASP includes matrix metalloproteinases (MMPs) — the enzymes that cleave collagen. It includes interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-α), which sustain chronic inflammation. It includes reactive oxygen species that damage mitochondrial DNA. One senescent cell doesn't age your skin. A thousand do.
The NAD⁺ Decline
Nicotinamide adenine dinucleotide (NAD⁺) is a coenzyme central to cellular metabolism. It's the electron carrier in the Krebs cycle, the substrate for sirtuin deacetylases, and the fuel for poly-ADP-ribose polymerases (PARPs) that repair DNA damage. Without NAD⁺, none of these systems work.
NAD⁺ levels decline with age — sharply. Research from the Sinclair lab at Harvard Medical School published in Cell in 2013 showed that NAD⁺ levels in mice drop roughly 50% between youth and old age. Human data from Massudi and colleagues (2012, PLoS ONE) showed a similar pattern: NAD⁺ concentrations in human skin tissue decline significantly after age 40.
The consequences cascade. Sirtuins — a family of seven NAD⁺-dependent deacetylases, first characterised by the Guarente lab at MIT — regulate DNA repair, mitochondrial biogenesis, and inflammatory gene expression. SIRT1 deacetylates and activates PGC-1α, the master regulator of mitochondrial production. SIRT6 deacetylates histones at DNA damage sites, enabling repair. When NAD⁺ drops, sirtuins go silent. DNA damage accumulates. Mitochondria degrade. The cell ages faster.
Autophagy: The Cellular Cleanup Crew
Cells generate waste. Misfolded proteins. Damaged mitochondria. Oxidised lipids. The clearance mechanism is autophagy — literally "self-eating" — by which a cell sequesters its damaged components in double-membrane vesicles and delivers them to lysosomes for degradation.
Autophagy was functionally unknown until Yoshinori Ohsumi identified the ATG (autophagy-related) genes in yeast in the 1990s, work that earned him the 2016 Nobel Prize in Physiology or Medicine. In human skin, autophagy is critical. Keratinocytes — the dominant cell type in the epidermis — rely on autophagy to clear UV-damaged proteins and maintain barrier function. A 2016 study by Akinduro and colleagues in the Journal of Investigative Dermatology showed that autophagy declines with age in human epidermis, and that this decline correlates with loss of barrier integrity.
When autophagy slows, damaged mitochondria aren't cleared efficiently. These mitochondria leak reactive oxygen species, which damage more mitochondria, which leak more ROS — a feed-forward loop that accelerates cellular aging. The cell becomes a landfill with the incinerator broken.
Mitochondrial Dysfunction
Mitochondria are not just power plants. They're signalling hubs that regulate apoptosis, calcium homeostasis, and cellular stress responses. In skin, dermal fibroblasts contain hundreds of mitochondria. Their function declines with age through multiple mechanisms: mtDNA damage from UV and ROS, decreased mitochondrial biogenesis (fewer new mitochondria produced), and impaired mitophagy (failure to clear damaged ones).
The López-Otín hallmarks paper identified mitochondrial dysfunction as a primary driver of aging. In skin, the evidence is visible. Aged fibroblasts show reduced ATP production, depolarized mitochondrial membranes, and morphological changes — mitochondria become swollen, fragmented, and fewer in number. These changes reduce the cell's capacity to synthesise collagen and elastin, to repair DNA, and to respond to stress.
The connection to NAD⁺ is direct: mitochondrial biogenesis depends on PGC-1α, which depends on SIRT1, which depends on NAD⁺. The NAD⁺ decline and mitochondrial dysfunction are not separate problems. They're two points on the same circuit.
Inflammaging: When Repair Becomes Destruction
The term inflammaging was coined by Claudio Franceschi at the University of Bologna to describe the chronic, low-grade, systemic inflammation that characterises aging. Unlike acute inflammation — the redness and swelling of a wound — inflammaging is silent, sustained, and destructive.
In skin, inflammaging is driven by multiple inputs: senescent cells releasing SASP factors, UV-damaged cells signalling distress, and gut-derived inflammatory mediators circulating systemically. Franceschi and Campisi described the feedback loop in a 2014 review in the Journal of Gerontology: inflammation damages cells, which senesce, which secrete more inflammatory factors, which damage more cells.
Clinically, inflammaging in skin manifests as slower wound healing, reduced collagen synthesis, increased MMP activity, and a weakened barrier. The skin doesn't just look older — it behaves older. It recovers slower. It produces less of what it needs and more of what it doesn't.
What Actually Works
This is the point where science meets intervention. The hallmarks are interconnected, but they're not equally actionable. Here's what the evidence supports:
UV protection is non-negotiable. UV radiation activates MMPs by 400-800% within hours of exposure, as demonstrated by Fisher and colleagues in the New England Journal of Medicine in 1997. It generates reactive oxygen species, damages mitochondrial DNA, accelerates telomere shortening, and drives senescence. Broad-spectrum sunscreen is the single most effective skin longevity intervention — and the only one where the evidence is unequivocal.
Copper peptide GHK-Cu addresses multiple hallmarks simultaneously. GHK-Cu — a tripeptide (glycyl-L-histidyl-L-lysine) complexed with copper — is one of the most studied peptides in dermatology. It upregulates collagen Type I and III synthesis through TGF-β signalling. It activates superoxide dismutase (SOD), neutralising the free radicals that drive inflammaging and mitochondrial damage. Research by Loren Pickart and colleagues, published across multiple journals including the Journal of Cosmetic Dermatology, has shown that GHK-Cu supports wound healing, reduces inflammatory cytokines, and resets the gene expression profile of aged fibroblasts toward a younger phenotype.
Antioxidants matter — but specifically. Vitamin C (L-ascorbic acid) is a required cofactor for prolyl hydroxylase and lysyl hydroxylase, the enzymes that stabilise the collagen triple helix. Without vitamin C, newly synthesised collagen cannot fold correctly. This is not theoretical — it's the mechanism behind scurvy. Vitamin E (α-tocopherol) is the primary lipid-soluble antioxidant in cell membranes, preventing lipid peroxidation that would otherwise generate inflammatory signals. These molecules aren't "antioxidants" in the vague marketing sense. They're specific cofactors in specific biochemical pathways.
What about NAD⁺ precursors? Nicotinamide (niacinamide, vitamin B3) is a NAD⁺ precursor with well-documented topical effects — it improves barrier function, reduces hyperpigmentation, and downregulates sebum production. But the systemic NAD⁺ boosters — nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) — have not been validated in topical formulations for human skin. The Sinclair lab's work on systemic NAD⁺ restoration is compelling for organismal aging, but topical translation is unproven. This is an area where the science is exciting and the data is not yet in.
What about senolytics? Compounds that selectively clear senescent cells — dasatinib, quercetin, fisetin — are among the most active areas of aging research. Early human trials are underway for systemic senolytics. Topical senolytics for skin are in preclinical development. There is no validated topical senolytic available today. This is not a critique — it's a statement about where the science sits.
What We Don't Know
Science is honest about its limits. Here are the open questions:
- Topical NAD⁺ restoration — Can topical NR, NMN, or NAD⁺ itself meaningfully restore dermal NAD⁺ pools? Human data is essentially absent.
- Autophagy induction — Rapamycin is a potent autophagy inducer, but it's an immunosuppressant. Topical rapamycin analogues are experimental.
- Epigenetic reprogramming — The Horvath epigenetic clock, developed at UCLA, can measure biological age in skin tissue. Partial epigenetic reprogramming (Yamanaka factors) has reversed aging markers in mice. Human skin application is years away.
- The senescence-skin interface — How many senescent cells are too many? At what threshold does SASP become clinically meaningful? These numbers aren't known.
- Interaction effects — How do interventions combine? Does GHK-Cu plus vitamin C produce additive effects, synergistic effects, or interference? Systematic combination studies are rare.
Acknowledging limits is not weakness. It's what distinguishes science from marketing.
How This Connects to NeoLabCare
I built NeoLabCare's formula around the interventions with the strongest mechanistic evidence and the fewest unknowns. The formulation includes GHK-Cu at its studied concentration range, delivered in a liposomal system that protects it from degradation. It includes vitamin C as L-ascorbic acid at a concentration sufficient for prolyl hydroxylase cofactor activity. It includes vitamin E for membrane lipid protection. And the vacuum pump system preserves these actives from oxidation — because a longevity molecule that has degraded before it reaches your skin provides exactly zero longevity benefit.
This isn't a product pitch. It's a statement of why the formula looks the way it does. Every inclusion has a biochemical rationale anchored to published evidence. Every exclusion — no retinol, no fragrance, no jar packaging — has the same rationale. The formula is a bet on the mechanisms described in this article. Time and data will tell if the bet was right.